Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
2.350
+0.020 (0.86%)
At close: Feb 11, 2026, 4:00 PM EST
2.370
+0.020 (0.85%)
Pre-market: Feb 12, 2026, 7:00 AM EST
Gossamer Bio Market Cap
Gossamer Bio has a market cap or net worth of $543.92 million as of February 12, 2026. Its market cap has increased by 160.68% in one year.
Market Cap
543.92M
Enterprise Value
566.57M
1-Year Change
160.68%
Ranking
Category
Stock Price
$2.35
Market Cap Chart
Since February 8, 2019, Gossamer Bio's market cap has decreased from $995.26M to $543.92M, a decrease of -45.35%. That is a compound annual growth rate of -8.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 543.92M | -24.19% |
| Dec 31, 2025 | 717.51M | 250.03% |
| Dec 31, 2024 | 204.99M | -0.34% |
| Dec 29, 2023 | 205.69M | 0.56% |
| Dec 30, 2022 | 204.54M | -76.06% |
| Dec 31, 2021 | 854.34M | 21.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ginkgo Bioworks Holdings | 556.71M |
| Contineum Therapeutics | 548.31M |
| Vor Biopharma | 537.27M |
| Evommune | 533.39M |
| Forte Biosciences | 532.98M |
| Keros Therapeutics | 528.28M |
| Solid Biosciences | 518.10M |
| REGENXBIO | 517.87M |